Free Trial
→ Many investors are about to lose everything (From Porter & Company) (Ad)tc pixel
NASDAQ:NUWE

Nuwellis Q3 2026 Earnings Date & Estimates

Nuwellis logo
$5.34 -0.57 (-9.56%)
As of 10:34 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Nuwellis is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. The conference call is scheduled for November 12, 2026 at 9:00 AM ET.

Research:ProfileEarnings HistoryForecast

Upcoming Earnings Announcement

Quarter
Q3 2026
Announcement Date
Time
Before Market Opens
Conference Call Date
Conference Call
9:00 AM ET
Google Calendar (opens in a new tab)Outlook (opens in a new tab)Yahoo Calendar (opens in a new tab)

What Analysts Expect from Nuwellis in Q3 2026

Nuwellis is expected to post earnings of -$122.85 per share on revenue of $2.51 million. In the same quarter a year earlier Nuwellis reported $176.40 per share on revenue of $2.22 million. Nuwellis last reported on August 13, 2026, posting -$239.76 per share and missing the -$214.20 consensus estimate.

Consensus Estimates

Consensus EPS
-$122.85
Expected Revenue
$2.51 million
Prior-Year EPS
$176.40
Prior-Year Revenue
$2.22 million
Expected EPS Growth
-169.6%
Expected Revenue Growth
+13.0%

Recent Track Record

Last Reported
Q2 2026
Last Quarter EPS
-$239.76 (Missed by -$25.56)
Last Quarter Revenue
$1.97 million

Prepare for the Q3 2026 Call

Nuwellis Q3 2026 Earnings FAQ

Nuwellis (NASDAQ:NUWE) is estimated to report Q3 2026 earnings on Wednesday, November 11, 2026, before market opens. This date is estimated from past reporting schedules and may change once the company confirms it.

Nuwellis' Q3 2026 earnings conference call is scheduled for Thursday, November 12, 2026 at 9:00 AM ET. MarketBeat streams the conference call audio and posts the transcript as soon as possible on the earnings announcement date.

Analysts expect Nuwellis to post earnings of -$122.85 per share for Q3 2026.

The consensus revenue estimate for Nuwellis is $2.51 million for Q3 2026.

Nuwellis Earnings Headlines

Nuwellis to Report Third Quarter 2026 Financial Results on November 12
 |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/11/04/3395310/26106/en/nuwellis-to-report-third-quarter-2026-financial-results-on-november-12.html
Nuwellis To Implement 1-for-9 Reverse Stock Split; Stock Down
October 28, 2026  |  rttnews.comhttps://www.rttnews.com/3704524/nuwellis-to-implement-1-for-9-reverse-stock-split-stock-down.aspx
Financial legend: “This is bad, really bad...”
Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.tc pixel
November 4 at 1:00 AM  |  Weiss Ratings (Ad)
Nuwellis Announces Acceptance of Multicenter Pediatric Aquadex Study in Pediatric Nephrology
October 27, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/27/3388904/26106/en/nuwellis-announces-acceptance-of-multicenter-pediatric-aquadex-study-in-pediatric-nephrology.html
Nuwellis, Inc. announces one-for-nine reverse stock split effective October 26, 2026
October 23, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/nuwellis-inc-announces-one-for-nine-reverse-stock-split-effective-october-26-2026/ar-AA2fVWLR
Nuwellis to Convene Pediatric Medical & Nursing Advisory Board to Advance Development of Vivian™ Pediatric CRRT System
October 8, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/10/08/3377268/26106/en/nuwellis-to-convene-pediatric-medical-nursing-advisory-board-to-advance-development-of-vivian-pediatric-crrt-system.html
See More Nuwellis Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Nuwellis? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Nuwellis and other key companies, straight to your email.

About Nuwellis

Nuwellis (NASDAQ:NUWE) is a medical device company focused on fluid management therapies for patients with fluid overload. The company develops and commercializes ultrafiltration technologies designed to remove excess salt and fluid from the blood when conventional diuretic therapy may be inadequate or poorly tolerated.

Nuwellis’ principal product is the Aquadex system, including the Aquadex FlexFlow system, a compact ultrafiltration platform used in hospital settings. The system is intended for temporary extracorporeal fluid removal in patients with conditions such as fluid overload associated with heart failure, renal dysfunction, and other critical-care needs. Nuwellis has also promoted applications of its technology in pediatric care.

The company was formerly known as CHF Solutions, Inc. and adopted the Nuwellis name in 2020. Its products are primarily marketed to hospitals and healthcare providers in the United States. Nuwellis is headquartered in Minneapolis, Minnesota, and focuses on expanding clinical applications and adoption of its ultrafiltration technology.

View Nuwellis Profile
Earnings Tools